Carrboro, NC, United States of America

Charles J Romeo

This inventor holds 1 USPTO granted patent. Top assignee: Molichem Medicines, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles J Romeo. Retrieved from https://idiyas.com/inventor/charles-j-romeo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles J. Romeo

Introduction

Charles J. Romeo is an accomplished inventor based in Carrboro, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acids. His work has implications for the manufacture of important pharmaceutical compounds.

Latest Patents

Charles J. Romeo holds a patent for "Nucleic acids encoding duramycin." This patent describes nucleic acids encoding preduramycin and produramycin, along with recombinant nucleic acids and host cells containing the same. The methods of use for these inventions include applications in the manufacture of the lantibiotic duramycin.

Career Highlights

Charles J. Romeo is associated with Molichem Medicines, Inc., where he continues to innovate in the field of medicinal chemistry. His expertise in nucleic acids has positioned him as a key player in the development of new therapeutic agents.

Collaborations

He collaborates with Luis Molina, contributing to the advancement of their shared goals in biotechnology and pharmaceutical development.

Conclusion

Charles J. Romeo's work exemplifies the impact of innovative thinking in the field of biotechnology. His contributions to nucleic acid technology are paving the way for new medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…